NR1H4 and metabolic dysfunction-associated steatotic liver disease: Bile acids and their metabolites act as signaling molecules through their binding to target cell receptors, such as the farnesoid X receptor (FXR), which is expressed in intestinal and liver cells and involved in ALD and NAFLD.